EFFECT OF MODERATE AND STRONG CYP3A INHIBITORS ON THE PHARMACOKINETICS OF PF-00489791, A SELECTIVE PDE5 INHIBITOR

Raje S.; Ripp S.; LaBadie R.; Alvey C.; Scheele W.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >EFFECT OF MODERATE AND STRONG CYP3A INHIBITORS ON THE PHARMACOKINETICS OF PF-00489791, A SELECTIVE PDE5 INHIBITOR

【24h】

EFFECT OF MODERATE AND STRONG CYP3A INHIBITORS ON THE PHARMACOKINETICS OF PF-00489791, A SELECTIVE PDE5 INHIBITOR

机译：中度和强CYP3A抑制剂对选择性PDE5抑制剂PF-00489791的药代动力学的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2016年第1期|共1页
作者
Raje S.; Ripp S.; LaBadie R.; Alvey C.; Scheele W.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. EFFECT OF MODERATE AND STRONG CYP3A INHIBITORS ON THE PHARMACOKINETICS OF PF-00489791, A SELECTIVE PDE5 INHIBITOR [J] . Raje S., Ripp S., LaBadie R., Clinical Pharmacology and Therapeutics . 2016,第Suppla1期

机译：中度和强CYP3A抑制剂对选择性PDE5抑制剂PF-00489791的药代动力学的影响
2. Exploratory Effects of a Strong CYP3A Inhibitor (Ketoconazole), a Strong CYP3A Inducer (Rifampicin), and Concomitant Ethanol on Piragliatin Pharmacokinetics and Pharmacodynamics in Type 2 Diabetic Patients [J] . Zhi Jianguo, Zhai Suoping, Georgy Angela, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2016,第5期

机译：强效CYP3A抑制剂（酮康唑），强效CYP3A诱导剂（利福平）和乙醇对2型糖尿病患者吡拉格列汀药代动力学和药效动力学的探索性作用
3. Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects. [J] . Garg A, Maes A, Corr C, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2011,第3期

机译：地尔硫卓（一种中度CYP3A抑制剂）对anacetrapib（一种有效的胆固醇酯转移蛋白抑制剂）的药代动力学的影响。
4. CNX-774, an Irreversible, Selective and Orally Bioavailable Inhibitor of Bruton's Tyrosine Kinase: In Vitro ADME, Selectivity, and Pharmacokinetic Properties [C] . Prasoon Chaturvedi, Matthew Labenski, Erica Evans, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：CNX-774，Bruton的酪氨酸激酶的不可逆转，选择性和口服生物可利用的抑制剂：体外Adme，选择性和药代动力学性能
5. Pharmacokinetics and pharmacodynamics of the selective serotonin reuptake inhibitors, fluoxetine and paroxetine, during pregnancy and the nursing period. [D] . Kim, John. 2001

机译：选择性5-羟色胺再摄取抑制剂氟西汀和帕罗西汀在怀孕和哺乳期的药代动力学和药效学。
6. Effect of ketoconazole a strong CYP3A inhibitor on the pharmacokinetics of venetoclax a BCL‐2 inhibitor in patients with non‐Hodgkin lymphoma [O] . Suresh K. Agarwal, Ahmed Hamed Salem, Alexey V. Danilov, 2017

机译：酮康唑（一种强CYP3A抑制剂）对非霍奇金淋巴瘤患者Venetoclax（一种BCL-2抑制剂）的药代动力学的影响
7. Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers [O] . Meera Tugnait, Neeraj Gupta, Michael J. Hanley, 2019

机译：强CYP2C8或CYP3A抑制和CYP3A诱导对Brigatinib的药代动力学，口腔血管性淋巴瘤激酶抑制剂，健康志愿者的影响

EFFECT OF MODERATE AND STRONG CYP3A INHIBITORS ON THE PHARMACOKINETICS OF PF-00489791, A SELECTIVE PDE5 INHIBITOR

著录项

相似文献

相关主题

期刊订阅